Cargando…
Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To date, liver biopsy has been the gold standard used to differentiate between simple steatosis and steatohepatitis/fibrosis. Our aim was to compare the relevance of serum non-invasive paramet...
Autores principales: | Dvorak, Karel, Stritesky, Jan, Petrtyl, Jaromir, Vitek, Libor, Sroubkova, Renata, Lenicek, Martin, Smid, Vaclav, Haluzik, Martin, Bruha, Radan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211730/ https://www.ncbi.nlm.nih.gov/pubmed/25350286 http://dx.doi.org/10.1371/journal.pone.0111551 |
Ejemplares similares
-
Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease
por: Petrtýl, Jaromír, et al.
Publicado: (2021) -
Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant
por: Leníček, Martin, et al.
Publicado: (2021) -
Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD
por: Šmíd, Václav, et al.
Publicado: (2022) -
Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration
por: Zelenka, Jaroslav, et al.
Publicado: (2016) -
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)